Those with similar patterns of cancer driver gene expression have poorer prognoses when they express higher levels of a subset of genes related to obesity or lipid metabolism (e.g. CD36 or TGF‐ß). Here, CD36 is linked to obesity due to melanocortin 4 receptor deficiency.